John E. More
Elstree, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Protective antibody concentrations in primary immunodeficiency following infusion with 5% or 10% intravenous immunoglobulin.
Journal: Allergy and asthma proceedings
Published: September 13, 2024
Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment - a sub-analysis of a randomized, cross-over bioequivalence trial.
Journal: PloS one
Published: July 03, 2023
Functional effects of haemoglobin can be rescued by haptoglobin in an in vitro model of subarachnoid haemorrhage.
Journal: Journal of neurochemistry
Published: April 19, 2023
Neurofilament light predicts neurological outcome after subarachnoid haemorrhage.
Journal: Brain : a journal of neurology
Published: June 16, 2020
Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin.
Journal: Brain communications
Published: April 30, 2020
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years' experience of the plasma protein manufacturers.
Journal: Transfusion
Published: November 20, 2019
Development of an intravenous immunoglobulin with improved safety and functional activity.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: April 04, 2014
Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.
Journal: Journal of immunological methods
Published: May 02, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026